PERFORMANCE ANATOMY
Performance anatomy is about culture, leadership, and the workforce and the critical role they each play in driving mindsets,
practices and results. Culture and leadership matter when it comes to explaining how some organizations achieve and sustain
high levels of performance. Becoming a high-performance pharmaceutical company will require moving away from an internally
focused organization to one with the ability to create a borderless culture that enables the organization to mesh quickly
with external partners. For example, instead of being a company that does proprietary R&D, a pharmaceutical company may move
to a model where it does significant joint development with other companies or has several partners from which to source innovation.
CONCLUSION
The time has come for large biopharmaceutical companies to make a clear choice about the business(es) in which they are in,
and how they can provide more targeted solutions. They'll need to stake a dominant market position based on differentiated
capabilities, divesting the assets that don't fit, acquiring those that do, and transforming their business to deliver solutions
that meet customer needs. To achieve high performance in the future, companies will need to develop new or significantly improved
capabilities in strategic deal-making, global expansion, analytics, and in digital and multichannel interactions. They will
need to develop new organizational cohesion to ensure alignment with improved customer outcomes. They will need to make hard
decisions about where to invest and what to divest. In conclusion, several factors and trends in the life-sciences industry
make consolidation an inevitable reality. Only through a rigorous process of strategic target identification, due diligence,
and seamless postmerger integration will tomorrow's leading companies lay the groundwork for sustainable shareholder value
and high performance.
Michael Brüeckner is managing director of Management Consulting for Life Sciences, and David Sheehy is a partner responsible for global strategy in Life Sciences, both at Accenture,
http://www.accenture.com/
|
